FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Daniel Weisdorf

Research Profile

Procedures

Disorders

Concepts & Ideas

Living Beings

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Bree Foley; Xianghua Luo; Claudio Anasetti; Sarah Cooley; Julie Curtsinger; Michael verneris; Edmund K Waller; Daniel Weisdorf; Jeffrey S Miller
Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.
Anna Petropoulou; Raphael Porcher; Patricia Ribaud; Félix Agbalika; Maryvonnick Carmagnat; Hélène Moins-Teisserenc; Régis Peffault de Latour; Paula Rodriguez-Otero; Gerard Socie; Alexis Talbot; Antoine Toubert; Daniel Weisdorf; Alienor Xhaard; Marie Robin
Increased infection rate after preemptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem-cell transplantation.
Yoshihiro Inamoto; David Jacobsohn; Madan H Jagasia; Nandita Khera; Stephanie J Lee; Paul J Martin; Jeanne Palmer; Steven Z Pavletic; Joseph Pidala; Barry E Storer; Georgia B Vogelsang; Daniel Weisdorf; Mukta Arora; Paul A Carpenter; Xiaoyu Chai; Corey Cutler; Mary E D Flowers
Clinical benefit of response in chronic graft-versus-host disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Daniel Weisdorf (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Bree Foley; Xianghua Luo; Claudio Anasetti; Sarah Cooley; Julie Curtsinger; Michael verneris; Edmund K Waller; Daniel Weisdorf; Jeffrey S Miller
Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.
Journal of immunology (Baltimore, Md. : 1950) 2012;189(10):5082-8.
2012: Anna Petropoulou; Raphael Porcher; Patricia Ribaud; Félix Agbalika; Maryvonnick Carmagnat; Hélène Moins-Teisserenc; Régis Peffault de Latour; Paula Rodriguez-Otero; Gerard Socie; Alexis Talbot; Antoine Toubert; Daniel Weisdorf; Alienor Xhaard; Marie Robin
Increased infection rate after preemptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem-cell transplantation.
Transplantation 2012;94(8):879-83.
2012: Yoshihiro Inamoto; David Jacobsohn; Madan H Jagasia; Nandita Khera; Stephanie J Lee; Paul J Martin; Jeanne Palmer; Steven Z Pavletic; Joseph Pidala; Barry E Storer; Georgia B Vogelsang; Daniel Weisdorf; Mukta Arora; Paul A Carpenter; Xiaoyu Chai; Corey Cutler; Mary E D Flowers
Clinical benefit of response in chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(10):1517-24.
2012: Daniel Weisdorf; David Porter; Edmond WALLER; Claudio Anasetti; Sarah Cooley; Julie Curtsinger; Todd E DeFor; Steven Devine; John DiPersio; William Drobyski; Sherif S Farag; Todd A Fehniger; Michael Haagenson; Jeffrey Miller
T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(6):937-43.
2012: Theodore Honebrink; Karen Larsen; Jeffery S Miller; Claudio G Brunstein; Michael J Burke; Qing Cao; Vanessa Dayton; John E Wagner; Daniel Weisdorf; Michael verneris
Impact of bone marrow hematogones on umbilical cord blood transplantation outcomes in patients with acute myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(6):930-6.
2012: Erica Warlick; Kwang Woo Ahn; Gorgun Akpek; Mahmoud Aljurf; Andrew Artz; Jean-Yves Cahn; Mitchell S Cairo; Yi-Bin Chen; Brenda Cooper; Marcos de Lima; Abhinav Deol; Sergio Giralt; Vikas Gupta; H Jean Khoury; Holbrook Kohrt; Hillard M Lazarus; Ian Lewis; Richard Olsson; Tanya L Pedersen; Joseph Pidala; Michael Allen Pulsipher; Bipin N Savani; Matthew Seftel; Gerard Socie; Martin Tallman; celalettin ustun; Ravi Vij; Lars Vindeløv; Daniel Weisdorf
Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era.
Blood 2012;119(17):4083-90.
2012: Yoshihiro Inamoto; David Jacobsohn; Madan H Jagasia; Nandita Khera; Brenda F Kurland; Stephanie J Lee; Paul J Martin; Jeanne M Palmer; Steven Z Pavletic; Joseph Pidala; Georgia B Vogelsang; Daniel Weisdorf; Paul A Carpenter; Xiaoyu Chai; Corey Cutler; Mary E D Flowers; Mary J Heffernan
Validation of measurement scales in ocular graft-versus-host disease.
Ophthalmology 2012;119(3):487-93.
2012: Dennis L Confer; David Weinstock; Daniel Weisdorf; Cullen Case; Nelson Chao
Radiation disasters: role of the BMT team.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(1 Suppl):S189-92.
2011: Daniel Weisdorf
Transplants for leukemia in relapse: when is the best time?
Best practice & research. Clinical haematology 2011;24(4):549-52.
2011: Dan T Vogl; Tao Wang; Daniel Weisdorf; Karen K Ballen; Asad Bashey; Cesar O Freytes; John Gibson; Daniel F Heitjan; Leona Holmberg; Ram Kamble; Robert A Kyle; Hillard M Lazarus; Dipnarine Maharaj; Angelo Maiolino; Philip L McCarthy; Waleska S Pérez; Vivek Roy; Edward A Stadtmauer; David H Vesole; Parameswaran Hari
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(12):1765-74.
2011: Betsy Hirsch; Bruce Lindgren; Xianghua Luo; John Miller; Leann Oseth; Shelley Pulkrabek; Erin Trader; Daniel Weisdorf; Meghan Cain; Mary Clay; Dennis Confer; Jeffrey McCullough
Effects of granulocyte-colony stimulating factor on chromosome aneuploidy and replication asynchrony in healthy peripheral blood stem cell donors.
Blood 2011;118(9):2602-8.
2011: Daniel Weisdorf; David Weinstock; Cullen Case; Nelson Chao; Dennis L Confer
Planning and response to radiation exposures.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(8):1262-3.
2011: P Ramírez; Claudio G Brunstein; Todd E DeFor; B Miller; Daniel Weisdorf
Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival.
Bone marrow transplantation 2011;46(7):981-6.
2011: Michael J Burke; Rachel Isaksson Vogel; Sanyukta K Janardan; Claudio G Brunstein; Angela R Smith; Jeffrey S Miller; Daniel Weisdorf; John E Wagner; Michael verneris
Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(6):831-40.
2011: Veronika Bachanova; Karamjeet Sandhu; Sophia Yohe; Qing Cao; Michael J Burke; Michael verneris; Daniel Weisdorf
Allogeneic hematopoietic stem cell transplantation overcomes the adverse prognostic impact of CD20 expression in acute lymphoblastic leukemia.
Blood 2011;117(19):5261-3.
2011: Melhem Solh; Claudio G Brunstein; Shanna Morgan; Daniel Weisdorf
Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(5):710-6.
2011: Betul Oran; Michelle Dolan; Qing Cao; Claudio G Brunstein; Erica Warlick; Daniel Weisdorf
Monosomal karyotype provides better prognostic prediction after allogeneic stem cell transplantation in patients with acute myelogenous leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(3):356-64.
2011: Paul J Martin; Barry E Storer; Paul A Carpenter; Daniel Couriel; Mary E D Flowers; Vikas Gupta; Jack W Hsu; Madan Jagasia; Carrie L Kitko; Richard T Maziarz; Scott D Rowley; Paul J Shaughnessy; Koen van Besien; Daniel Weisdorf; Stephanie J Lee
Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(1):124-32.
2010: K S Baker; K K Ness; Daniel Weisdorf; L Francisco; C-L Sun; Stephen Forman; Smita Bhatia
Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.
Leukemia 2010;24(12):2039-47.
2010: Veronika Bachanova; Linda J Burns; David H McKenna; Julie Curtsinger; Angela Panoskaltsis-Mortari; Bruce R Lindgren; Sarah Cooley; Daniel Weisdorf; Jeffrey S Miller
Allogeneic natural killer cells for refractory lymphoma.
Cancer immunology, immunotherapy : CII 2010;59(11):1739-44.
2010: Matthew S Davids; Cullen Case; Raymond Hornung; Nelson J Chao; John P Chute; C Norman Coleman; Daniel Weisdorf; Dennis L Confer; David M Weinstock
Assessing surge capacity for radiation victims with marrow toxicity.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(10):1436-41.
2010: Michel Duval; John P Klein; Wensheng He; Jean-Yves Cahn; Mitchell S Cairo; Bruce M Camitta; Rammurti Kamble; Edward A Copelan; Marcos de Lima; Vikas Gupta; Armand Keating; Hillard M Lazarus; Mark R Litzow; David I Marks; Richard T Maziarz; David A Rizzieri; Gary Schiller; Kirk R Schultz; Martin S Tallman; Daniel Weisdorf
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(23):3730-8.
2010: Mukta Arora; Bruce R Lindgren; Saonli Basu; S Nagaraj; M Gross; Daniel Weisdorf; Bharat Thyagarajan
Polymorphisms in the base excision repair pathway and graft-versus-host disease.
Leukemia 2010;24(8):1470-5.
2010: Steven Z Pavletic; Shaji Kumar; Mohamad Mohty; Marcos de Lima; James M Foran; Marcelo Pasquini; Mei-Jie Zhang; Sergio Giralt; Michael Bishop; Daniel Weisdorf
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(7):871-90.
2010: Pamala A Jacobson; Jiayin Huang; Juan Wu; Miae Kim; Brent Logan; Amin Alousi; Michael Grimley; F. JAVIER BOLANOS MEADE; Vincent Ho; John E Levine; Daniel Weisdorf
Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(3):421-9.
2009: Parameswaran Hari; Mei-Jie Zhang; Vivek Roy; Waleska S Pérez; Asad Bashey; L Bik To; Gerald J Elfenbein; Cesar O Freytes; Robert Peter Gale; John Gibson; Robert A Kyle; Hillard M Lazarus; Philip L McCarthy; Gustavo A Milone; Santiago Pavlovsky; Donna Reece; Gary Schiller; J Vela-Ojeda; Daniel Weisdorf; David H Vesole
Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant.
Leukemia 2009;23(8):1528-34.
2009: Paul J Martin; Carlos R Bachier; Hans-Georg Klingemann; Philip L McCarthy; Paul Szabolcs; Joseph Primo Uberti; Michael W Schuster; Daniel Weisdorf; Nelson J Chao; Partow Kebriaei; Elizabeth J Shpall; Margaret L Macmillan; Robert J Soiffer
Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(7):777-84.
2009: Pamala Jacobson; S F El-Massah; John Rogosheske; A Kerr; J Long-Boyle; Todd E DeFor; C Jennissen; Claudio G Brunstein; J Wagner; M Tomblyn; Daniel Weisdorf
Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation.
Bone marrow transplantation 2009;44(2):113-20.
2009: Paul J Martin; Barry E Storer; Scott D Rowley; Mary E D Flowers; Stephanie J Lee; Paul A Carpenter; John R Wingard; Paul J Shaughnessy; Marcel P Devetten; Madan Jagasia; Joseph W Fay; Koen van Besien; Vikas Gupta; Carrie L Kitko; Laura J Johnston; Richard T Maziarz; Mukta Arora; Pamala A Jacobson; Daniel Weisdorf
Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.
Blood 2009;113(21):5074-82.
2009: Daniel Weisdorf; Stephen Forman
Allogeneic hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia.
Cancer treatment and research 2009;144():441-54.
2009: Erica D Warlick; Adina Cioc; Todd E DeFor; Michelle Dolan; Daniel Weisdorf
Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1):30-8.
2008: Jason Dehn; Mukta Arora; Stephen Spellman; Michelle Setterholm; Mary Horowitz; Dennis L Confer; Daniel Weisdorf
Unrelated donor hematopoietic cell transplantation: factors associated with a better HLA match.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(12):1334-40.
2008: Daniel Weisdorf
Introduction: 20th anniversary of the NMDP.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(9 Suppl):1.
2008: Daniel Weisdorf; Stephen Spellman; Michael Haagenson; Mary Horowitz; Stephanie Lee; Claudio Anasetti; Michelle Setterholm; Rebecca Drexler; Martin Maiers; Roberta King; Dennis L Confer; John Klein
Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(7):748-58.
2008: Paul D Harker-Murray; Avis J Thomas; John E Wagner; Daniel Weisdorf; Xianghua Luo; Todd E DeFor; Michael verneris; Kathryn E Dusenbery; Margaret L MacMillan; Jakub Tolar; K Scott Baker; Paul J Orchard
Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(6):685-92.
2008: Kebede Hussein; Balkrishna Jahagirdar; Pankaj Gupta; Linda J Burns; Karen Larsen; Daniel Weisdorf
Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia.
American journal of hematology 2008;83(6):446-50.
2008: Daniel Weisdorf
Should all unrelated donors for transplantation be matched?
Best practice & research. Clinical haematology 2008;21(1):79-83.
2008: V Bachanova; Daniel Weisdorf
Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review.
Bone marrow transplantation 2008;41(5):455-64.
2007: Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn Katovich Hurley; Harriet Noreen; Machteld Oudshoorn; Effie W Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.
Blood 2007;110(13):4576-83.
2007: John P Leonard; Brian K Link; Christos Emmanouilides; Stephanie A Gregory; Daniel Weisdorf; Jeffrey Andrey; John Hainsworth; Joseph A Sparano; Donald E Tsai; Sandra Horning; Arthur M Krieg; George J Weiner
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6168-74.
2007: Catherine M Flynn; Betsy Hirsch; Todd E DeFor; Juliet N Barker; Jeffrey S Miller; John E Wagner; Bruce R Blazar; Linda J Burns; Margaret L MacMillan; Mukta Arora; Daniel Weisdorf
Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysis.
American journal of hematology 2007;82(10):867-72.
2007: Sergio Giralt; Brent Logan; Douglas Rizzo; Mei-Jie Zhang; Karen K Ballen; Christos Emmanouilides; Rajneesh Nath; Pablo Parker; David Porter; Brenda M Sandmaier; Edmond WALLER; Juliet N Barker; Steven Z Pavletic; Daniel Weisdorf
Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(7):844-52.
2007: Daniel Weisdorf; Shelly Carter; Dennis L Confer; James L M Ferrara; Mary Horowitz
Blood and marrow transplant clinical trials network (BMT CTN): addressing unanswered questions.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):257-62; discussion 255-6.
2007: K Scott Baker; Kirsten K Ness; Julia Steinberger; Andrea Carter; Liton Francisco; Linda J Burns; Charles A Sklar; Stephen Forman; Daniel Weisdorf; James G Gurney; Smita Bhatia
Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study.
Blood 2007;109(4):1765-72.
2007: Pamala Jacobson; Kathleen Green; John Rogosheske; Claudio G Brunstein; Breta Ebeling; Todd E DeFor; Philip B McGlave; Daniel Weisdorf
Highly variable mycophenolate mofetil bioavailability following nonmyeloablative hematopoietic cell transplantation.
Journal of clinical pharmacology 2007;47(1):6-12.
2006: Christopher J Fraser; Smita Bhatia; Kirsten K Ness; Andrea Carter; Liton Francisco; Mukta Arora; Pablo Parker; Stephen Forman; Daniel Weisdorf; James G Gurney; K Scott Baker
Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.
Blood 2006;108(8):2867-73.
2006: Brian K Link; Zuhair K Ballas; Daniel Weisdorf; James E Wooldridge; Aaron D Bossler; Mary Shannon; Wendy L Rasmussen; Arthur M Krieg; George J Weiner
Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(5):558-68.
2006: Sherif S Farag; Andrea Bacigalupo; Mary Eapen; Carolyn Hurley; Bo Dupont; Michael A Caligiuri; Christian Boudreau; Gene Nelson; Machteld Oudshoorn; Jon van Rood; Andrea Velardi; Martin Maiers; Michelle Setterholm; Dennis L Confer; Phillip E Posch; Claudio Anasetti; Naynesh Kamani; Jeffrey S Miller; Daniel Weisdorf; Stella M Davies
The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(8):876-84.
2006: Noel Laudi; Mukta Arora; Linda J Burns; Philip B McGlave; Jeffrey Miller; Gerald Bohac; Tyson Rogers; Juliet N Barker; James E Coad; Daniel Weisdorf
Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma.
American journal of hematology 2006;81(7):519-24.
2006: Juki Ng; John Rogosheske; Juliet N Barker; Daniel Weisdorf; Pamala A Jacobson
A limited sampling model for estimation of total and unbound mycophenolic acid (MPA) area under the curve (AUC) in hematopoietic cell transplantation (HCT).
Therapeutic drug monitoring 2006;28(3):394-401.
2006: Daniel Weisdorf; Nelson Chao; Jamie K Waselenko; Nicholas Dainiak; James O Armitage; Ian K McNiece; Dennis L Confer
Acute radiation injury: contingency planning for triage, supportive care, and transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(6):672-82.
2006: Paul J Martin; Daniel Weisdorf; Donna Przepiorka; Steven Hirschfeld; Ann Farrell; J Douglas Rizzo; Ronan Foley; Gerard Socie; Shelly Carter; Daniel Couriel; Kirk R Schultz; Mary E D Flowers; Alexandra H Filipovich; Rima M Saliba; Georgia B Vogelsang; Steven Z Pavletic; Stephanie J Lee
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):491-505.
2006: Kirk R Schultz; David B Miklos; Daniel Fowler; Ken Cooke; Judith A Shizuru; Emmanuel Zorn; Ernst Holler; James L M Ferrara; Howard M Shulman; Stephanie J Lee; Paul Martin; Alexandra H Filipovich; Mary E D Flowers; Daniel Weisdorf; Daniel Couriel; Peter A Lachenbruch; Barbara Mittleman; Georgia B Vogelsang; Steven Z Pavletic
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(2):126-37.
2005: Pamala Jacobson; Janel Long; John Rogosheske; Claudio G Brunstein; Daniel Weisdorf
High unbound mycophenolic acid concentrations in a hematopoietic cell transplantation patient with sepsis and renal and hepatic dysfunction.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(12):977-8.
2005: Alexandra H Filipovich; Daniel Weisdorf; Steven Z Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia A Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk R Schultz; Howard M Shulman; Maria Turner; Georgia B Vogelsang; Mary E D Flowers
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(12):945-56.
2005: Pamala Jacobson; John Rogosheske; Juliet N Barker; Kathleen Green; Juki Ng; Daniel Weisdorf; Ye Tan; Janel Long; Rory P Remmel; Ronald Sawchuk; Philip B McGlave
Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation.
Clinical pharmacology and therapeutics 2005;78(5):486-500.
2005: Steven Z Pavletic; Shelly L Carter; Nancy A Kernan; Jean Henslee-Downey; Adam M Mendizabal; Esperanza B Papadopoulos; Roger Gingrich; James T Casper; Saul Yanovich; Daniel Weisdorf
Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation.
Blood 2005;106(9):3308-13.
2005: G de Lissovoy; David D Hurd; S Carter; P Beatty; Marian Ewell; Jean Henslee-Downey; Nancy A Kernan; Saul Yanovich; Daniel Weisdorf
Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease.
Bone marrow transplantation 2005;36(6):539-46.
2005: Steven Z Pavletic; Issa F Khouri; Michael Haagenson; Roberta J King; Philip J Bierman; Michael Bishop; Michael Carston; Sergio Giralt; Arturo Molina; Edward A Copelan; Olle Ringdén; Vivek Roy; Karen K Ballen; Douglas R Adkins; Philip McCarthy; Daniel Weisdorf; Emili Montserrat; Claudio Anasetti
Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5788-94.
2004: Ricardo Spielberger; Patrick J Stiff; William I Bensinger; Teresa Gentile; Daniel Weisdorf; Tarun Kewalramani; Thomas Shea; Saul Yanovich; Keith Hansen; Stephen J Noga; John McCarty; Charles F LeMaistre; Eric C Sung; Bruce R Blazar; Dieter Elhardt; Mon-Gy Chen; Christos Emmanouilides
Palifermin for oral mucositis after intensive therapy for hematologic cancers.
The New England journal of medicine 2004;351(25):2590-8.
2004: Joseph H Antin; Allen R Chen; Daniel Couriel; Vincent T Ho; Richard A Nash; Daniel Weisdorf
Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(10):655-68.
2004: Neal Flomenberg; Lee Ann Baxter-Lowe; Dennis L Confer; Marcelo Fernandez-Vina; Alexandra H Filipovich; Mary Horowitz; Carolyn Hurley; Craig Kollman; Claudio Anasetti; Harriet Noreen; Ann B Begovich; William H Hildebrand; Effie W Petersdorf; Barbara Schmeckpeper; Michelle Setterholm; Elizabeth Trachtenberg; Thomas Williams; Edmond J Yunis; Daniel Weisdorf
Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.
Blood 2004;104(7):1923-30.
2004: Steven M Devine; Neal Flomenberg; David H Vesole; Jane L Liesveld; Daniel Weisdorf; Karin Badel; Gary Calandra; John F DiPersio
Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):1095-102.
2003: Carolyn Katovich Hurley; Lee Ann Baxter-Lowe; Brent Logan; Chatchada Karanes; Claudio Anasetti; Daniel Weisdorf; Dennis L Confer
National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(10):610-5.
2003: E Dahl; J Burroughs; T DeFor; C Verfaillie; Daniel Weisdorf
Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
Bone marrow transplantation 2003;32(6):575-80.
2003: Daniel Anderson; Todd E DeFor; Linda J Burns; Philip B McGlave; Jeffrey Miller; John Wagner; Daniel Weisdorf
A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(1):52-9.
2002: Joseph H Antin; Daniel Weisdorf; Donna Neuberg; Roberta Nicklow; Shawn Clouthier; Stephanie J Lee; Edwin P Alyea; Carol McGarigle; Bruce R Blazar; Stephen Sonis; Robert J Soiffer; James L M Ferrara
Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation.
Blood 2002;100(10):3479-82.
2002: Daniel Weisdorf; Michael Bishop; Bernie Dharan; Brian J Bolwell; Jean Yves Cahn; Mitchell S Cairo; Sergio Giralt; John Klein; Hillard M Lazarus; Mark R Litzow; David Marks; Philip McCarthy; Carole B Miller; Gustavo A Milone; James Russell; Kirk R Schultz; Jorge Sierra; Peter H Wiernik; Armand Keating; Fausto R Loberiza; Craig Kollman; Mary Horowitz
Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(4):213-20.
2001: Effie W Petersdorf; Craig Kollman; Carolyn Katovich Hurley; Bo Dupont; Auayporn Nademanee; Ann B Begovich; Daniel Weisdorf; Philip B McGlave
Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
Blood 2001;98(10):2922-9.
2001: Carole B Miller; Philip Rowlings; M J Zhang; Richard J Jones; Steven Piantadosi; A Keating; J O Armitage; Stan Calderwood; R E Harris; J P Klein; H M Lazarus; C A Linker; Kathleen A Sobocinski; Daniel Weisdorf; M M Horowitz
The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.
Experimental hematology 2001;29(11):1336-46.
2001: Craig Kollman; C W Howe; Claudio Anasetti; Joseph H Antin; Stella M Davies; Alexandra H Filipovich; Janet Hegland; Naynesh Kamani; Nancy A Kernan; Roberta King; Voravit Ratanatharathorn; Daniel Weisdorf; Dennis L Confer
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.
Blood 2001;98(7):2043-51.
2001: Joseph H Antin; R Childs; Alexandra H Filipovich; Sergio Giralt; S Mackinnon; Thomas R Spitzer; Daniel Weisdorf
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(9):473-85.
2000: Martin S Tallman; Philip Rowlings; Gustavo A Milone; Mei-Jie Zhang; Waleska S Perez; Daniel Weisdorf; Armand Keating; Robert Peter Gale; R B Geller; Mary J Laughlin; Hillard M Lazarus; S M Luger; Philip L McCarthy; J M Rowe; RA Saez; MR Vowels; Mary M Horowitz
Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission.
Blood 2000;96(4):1254-8.
2000: Louise Cragg; B R Blazar; Todd E DeFor; N Kolatker; Wesley J Miller; John H Kersey; M Ramsay; Philip B McGlave; Alexandra H Filipovich; Daniel Weisdorf
A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(4A):441-7.
1999: Gérard Socié; JV Stone; J R Wingard; Daniel Weisdorf; PJ Henslee-Downey; Christopher N Bredeson; J Y Cahn; Jakob R Passweg; Philip Rowlings; H C Schouten; Hans-Jochem Kolb; John P Klein
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
The New England journal of medicine 1999;341(1):14-21.
1999: Paul J Orchard; John Rogosheske; Linda J Burns; N Rydholm; H Larson; Todd E DeFor; Norma K C Ramsay; Daniel Weisdorf
A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(6):386-93.
1998: Voravit Ratanatharathorn; Richard A Nash; Donna Przepiorka; Steven M Devine; Jared L Klein; Daniel Weisdorf; Joseph W Fay; Auayporn Nademanee; Joseph H Antin; Neal Christiansen; R van der Jagt; Roger H Herzig; Mark R Litzow; Steven Neil Wolff; W L Longo; F B Petersen; Chatchada Karanes; Belinda R Avalos; Rainer Storb; Donald N Buell; Rochelle M Maher; William E Fitzsimmons; John R Wingard
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
Blood 1998;92(7):2303-14.
1998: Catherine M Verfaillie; R Bhatia; Michael Steinbuch; Todd E DeFor; Betsy Hirsch; Jeffrey S Miller; Daniel Weisdorf; Philip B McGlave
Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells.
Blood 1998;92(5):1820-31.
1998: Smita Bhatia; Norma K C Ramsay; Daniel Weisdorf; H Griffiths; L L Robison
Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies.
Bone marrow transplantation 1998;22(1):87-90.
1998: C Arns da Cunha; Daniel Weisdorf; X O Shu; Todd E DeFor; J D Pastor; J R Johnson
Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis.
Bone marrow transplantation 1998;21(2):173-80.
1997: Daniel Weisdorf; Jeffrey Miller; Catherine M Verfaillie; Linda J Burns; J Wagner; Bruce R Blazar; S Davies; Wesley J Miller; P Hannan; Michael Steinbuch; Norma K C Ramsay; Philip B McGlave
Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(4):217-23.
1997: Daniel D Billadeau; F Prosper; C Verfaillie; Daniel Weisdorf; Brian Van Ness
Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement.
Leukemia 1997;11(9):1565-70.
1997: V Roy; L Ochs; Daniel Weisdorf
Late infections following allogeneic bone marrow transplantation: suggested strategies for prophylaxis.
Leukemia & lymphoma 1997;26(1-2):1-15.
1997: Jeffrey S Miller; J Tessmer-Tuck; B A Pierson; Daniel Weisdorf; Philip B McGlave; Bruce R Blazar; E Katsanis; Catherine M Verfaillie; J Lebkowski; J Radford; Linda J Burns
Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(1):34-44.
1997: V Roy; Daniel Weisdorf
Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review.
Bone marrow transplantation 1997;19(5):467-70.
1996: H Enright; Stella M Davies; Todd E DeFor; X Shu; Daniel Weisdorf; Wesley J Miller; Norma K C Ramsay; D Arthur; Catherine M Verfaillie; J Miller; J Kersey; Philip B McGlave
Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.
Blood 1996;88(2):714-20.
1995: L Ochs; X O Shu; J Miller; H Enright; J Wagner; Alexandra H Filipovich; Wesley J Miller; Daniel Weisdorf
Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients.
Blood 1995;86(10):3979-86.
1995: Raleigh A Bowden; Sherrill J Slichter; M Sayers; Daniel Weisdorf; M Cays; Gary Schoch; M Banaji; R Haake; K Welk; Lloyd Fisher; J McCullough; Wesley J Miller
A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.
Blood 1995;86(9):3598-603.
1995: E W Greeno; R Haake; Philip B McGlave; Daniel Weisdorf; Catherine M Verfaillie
Lupus inhibitors following bone marrow transplant.
Bone marrow transplantation 1995;15(2):287-91.
1994: Daniel Weisdorf; E Katsanis; Catherine M Verfaillie; Norma K C Ramsay; R Haake; L Garrison; Bruce R Blazar
Interleukin-1 alpha administered after autologous transplantation: a phase I/II clinical trial.
Blood 1994;84(6):2044-9.
1994: C S Han; Wesley J Miller; R Haake; Daniel Weisdorf
Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.
Bone marrow transplantation 1994;13(3):277-83.
1993: Daniel Weisdorf; Alexandra H Filipovich; Philip B McGlave; Norma K C Ramsay; J Kersey; Wesley J Miller; Bruce R Blazar
Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation.
Bone marrow transplantation 1993;12(5):531-6.
1993: fatih uckun; J H Kersey; R Haake; Daniel Weisdorf; M E Nesbit; N K Ramsay
Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia.
The New England journal of medicine 1993;329(18):1296-301.
1993: J Kersey; Alexandra H Filipovich; Philip B McGlave; W Woods; Daniel Weisdorf; Joseph P Neglia; K Dusenbery; Bruce R Blazar; M Nesbit; Norma K C Ramsay
Donor and host influences in bone marrow transplantation for immunodeficiency disease and leukemia.
Seminars in hematology 1993;30(4 Suppl 4):105-8; discussion 109.
1993: H Enright; R Haake; Daniel Weisdorf; Norma K C Ramsay; Philip B McGlave; J Kersey; W Thomas; D McKenzie; Wesley J Miller
Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy.
Transplantation 1993;55(6):1339-46.
1993: M Steiner; Judith G Villablanca; J Kersey; Norma K C Ramsay; R Haake; P Ferrieri; Daniel Weisdorf
Viridans streptococcal shock in bone marrow transplantation patients.
American journal of hematology 1993;42(4):354-8.
1992: fatih uckun; S Haissig; Jeffrey A Ledbetter; P Fidler; DE Myers; V Kuebelbeck; Daniel Weisdorf; K Gajl-Peczalska; J H Kersey; Norma K C Ramsay
Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein.
Blood 1992;79(12):3369-79.
1992: H Enright; Daniel Weisdorf; L Peterson; R E Rydell; M E Kaplan; D C Arthur
Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia.
Leukemia 1992;6(5):381-4.
1992: fatih uckun; John H Kersey; R Haake; Daniel Weisdorf; Norma K C Ramsay
Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
Blood 1992;79(4):1094-104.
1992: J Kersey; Daniel Weisdorf; fatih uckun; D Vallera; B Jansen; M Nesbit; R Haake; Norma K C Ramsay
Allogeneic and autologous bone marrow transplantation for high risk acute lymphoblastic leukemia.
Leukemia 1992;6 Suppl 2():191-2.
1991: C Verfaillie; Daniel Weisdorf; R Haake; M Hostetter; Norma K C Ramsay; Philip B McGlave
Candida infections in bone marrow transplant recipients.
Bone marrow transplantation 1991;8(3):177-84.
1991: J Roy; G Vercellotti; M Fenderson; A Mulvahill; D Snover; Daniel Weisdorf
Isolated relapse of acute myelogenous leukemia presenting as a gastric ulcer.
American journal of hematology 1991;37(4):270-3.
1991: Daniel Weisdorf; R Hakke; Bruce R Blazar; Wesley J Miller; Philip B McGlave; Norma K C Ramsay; J Kersey; Alexandra H Filipovich
Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation.
Transplantation 1991;51(6):1197-203.
1991: P Ely; J Dunitz; John Rogosheske; Daniel Weisdorf
Use of a somatostatin analogue, octreotide acetate, in the management of acute gastrointestinal graft-versus-host disease.
The American journal of medicine 1991;90(6):707-10.
1991: J Roy; D Snover; S Weisdorf; A Mulvahill; Alexandra H Filipovich; Daniel Weisdorf
Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease.
Transplantation 1991;51(3):642-6.
1990: H Enright; R Haake; Daniel Weisdorf
Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation.
The American journal of medicine 1990;89(6):733-8.
1990: fatih uckun; J H Kersey; D A Vallera; Jeffrey A Ledbetter; Daniel Weisdorf; DE Myers; R Haake; Norma K C Ramsay
Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging.
Blood 1990;76(9):1723-33.
1990: Judith G Villablanca; M Steiner; J Kersey; Norma K C Ramsay; P Ferrieri; R Haake; Daniel Weisdorf
The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients.
Bone marrow transplantation 1990;5(6):387-93.
1990: Daniel Weisdorf; R Haake; Bruce R Blazar; Wesley J Miller; Philip B McGlave; Norma K C Ramsay; J Kersey; Alexandra H Filipovich
Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome.
Blood 1990;75(4):1024-30.
1990: Daniel Weisdorf; Norma K C Ramsay; T LeBien; W Woods; Bruce C Bostrom; M Nesbit; D Vallera; fatih uckun; A Goldman; T Kim
Allogeneic and autologous bone marrow transplantation for acute lymphoblastic leukemia.
Haematology and blood transfusion 1990;33():679-83.
1989: Daniel Weisdorf; D Arthur; J Rank; Bruce R Blazar; K Gajl-Peczalska; D Snover
Gastric recurrence of acute lymphoblastic leukaemia mimicking graft-versus-host disease.
British journal of haematology 1989;71(4):559-61.
1989: Daniel Weisdorf; D Hasegawa; D S Fair
Acquired factor VII deficiency associated with aplastic anaemia: correction with bone marrow transplantation.
British journal of haematology 1989;71(3):409-13.
1989: D C Snover; S Weisdorf; Joseph R Bloomer; P McGlave; Daniel Weisdorf
Nodular regenerative hyperplasia of the liver following bone marrow transplantation.
Hepatology (Baltimore, Md.) 1989;9(3):443-8.
1988: Philip B McGlave; R J Haake; Bruce C Bostrom; R Brunning; D D Hurd; T H Kim; M E Nesbit; Gregory M Vercellotti; Daniel Weisdorf; W G Woods
Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remission.
Blood 1988;72(5):1512-7.
1987: J H Kersey; Daniel Weisdorf; M E Nesbit; T W LeBien; W G Woods; P B McGlave; T Kim; D A Vallera; A I Goldman; Bruce C Bostrom
Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.
The New England journal of medicine 1987;317(8):461-7.
1987: Philip B McGlave; D Arthur; R Haake; D Hurd; Wesley J Miller; G Vercellotti; Daniel Weisdorf; T Kim; Norma K C Ramsay; J Kersey
Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(7):1033-40.
1987: Bruce C Bostrom; W G Woods; M E Nesbit; W Krivit; J Kersey; Daniel Weisdorf; R Haake; A I Goldman; N K Ramsay
Successful reinduction of patients with acute lymphoblastic leukemia who relapse following bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(3):376-81.
1985: Norma K C Ramsay; T LeBien; M Nesbit; Philip B McGlave; Daniel Weisdorf; P Kenyon; D Hurd; A Goldman; T Kim; J Kersey
Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement.
Blood 1985;66(3):508-13.
1984: P B McGlave; D C Arthur; Daniel Weisdorf; T Kim; A Goldman; D D Hurd; N K Ramsay; J H Kersey
Allogeneic bone marrow transplantation as treatment for accelerating chronic myelogenous leukemia.
Blood 1984;63(1):219-22.